Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model
JCI Insight · 08.05.2026 · 11 (9)
DOI: 10.1172/jci.insight.198095 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 08.05.2026. Verfasst von Isaline Louvet und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of Lille, CHU Lille, Inserm U1190, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 1-alpha, Diabetes Mellitus, Type 2. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Foundation for the Study of Diabetes/Novo Nordisk, European Foundation for the Study of Diabetes/Lilly, I-SITE ULNE.
Abstract (Originalsprache)
HNF1A-MODY, the most common monogenic diabetes, exhibits progressive β cell dysfunction, but existing mouse models fail to recapitulate human disease progression, limiting understanding of pathogenic mechanisms. We developed mice with heterozygous deletion of the Hnf1a transactivation domain ( Hnf1a +/ Δ e4-10 ) to model human HNF1A haploinsufficiency, conducted cross-sectional metabolic characterization, and validated our findings in HNF1A-deficient human islets. Unlike previous models, Hnf1a +/ Δ e4-10 mice successfully recapitulated temporal HNF1A-MODY progression. Male mice developed sequential pathophysiology: early insulin resistance in young adults (7 weeks), followed by testosterone deficiency and fasting hyperglycemia in adult mice (10 weeks). Glucose intolerance emerged in middle-aged mice (30 weeks), progressing to multi-organ dysfunction in aged mice (44–70 weeks), characterized by elevated hepatic gluconeogenesis, impaired renal glucose handling, and hepatic steatosis/fibrosis. This dual pathophysiology involving β cell dysfunction and peripheral insulin resistance was associated with dysregulated hormone secretion from both α and β cells in aged mice (40–70 weeks). Human islet studies with HNF1A knockdown confirmed translational relevance, demonstrating reduced SGLT2 protein expression and inappropriate glucagon and insulin secretion. This work established a physiologically relevant HNF1A-MODY model, identified early insulin resistance as a key mechanism triggering hormonal dysfunction, and revealed HNF1A’s role in multi-organ pathophysiology beyond traditional β cell dysfunction. New mouse model reveals HNF1A-MODY diabetes involves early insulin resistance and testosterone deficiency before β-cell failure, affecting multiple organs beyond the pancreas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Lille, CHU Lille, Inserm U1190, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille, France.
- Laboratory of Development and Plasticity of the Neuroendocrine Brain, FHU 1000 Days for Health, School of Medicine, Lille, France.
- University of Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.
- Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
Förderung
- European Foundation for the Study of Diabetes/Novo Nordisk
- European Foundation for the Study of Diabetes/Lilly
- I-SITE ULNE
- European Consortium for Islet Transplantation through the Juvenile Diabetes Research Foundation
- European Genomic Institute for Diabetes
Zitieren
APA
Louvet, I., Acosta-Montalvo, A., Saponaro, C., Moreno-Lopez, M., Douffi, S., El Karchaoui, A., Pasquetti, G., Thevenet, J., Delalleau, N., Gmyr, V., Giacobini, P., Espiard, S., Kerr-Conte, J., Pattou, F., Liston, A., & Bonner, C. (2026). Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model. JCI Insight, 11(9). https://doi.org/10.1172/jci.insight.198095
Vancouver
Louvet I, Acosta-Montalvo A, Saponaro C, Moreno-Lopez M, Douffi S, El Karchaoui A, et al. Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model. JCI Insight. 2026;11(9). doi:10.1172/jci.insight.198095
BibTeX
@article{Louvet2026,
author = {Louvet, Isaline and Acosta-Montalvo, Ana and Saponaro, Chiara and Moreno-Lopez, Maria and Douffi, Sana and El Karchaoui, Abdelkrim and Pasquetti, Gianni and Thevenet, Julien and Delalleau, Nathalie and Gmyr, Valery and Giacobini, Paolo and Espiard, Stéphanie and Kerr-Conte, Julie and Pattou, François and Liston, Adrian and Bonner, Caroline},
title = {Progressive HNF1A-MODY pathophysiology revealed by a translational mouse model},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {9},
doi = {10.1172/jci.insight.198095}
}
EUVIMED